Literature DB >> 12372993

Mitochondrial DNA mutations and oxidative damage in skeletal muscle of patients with chronic uremia.

Paik-Seong Lim1, Yi-Shing Ma, Yueh-Mei Cheng, Henry Chai, Cheng-Feng Lee, Tzu-Ling Chen, Yau-Huei Wei.   

Abstract

Abundant evidence has been gathered to suggest that mitochondrial DNA (mtDNA) sustains many more mutations and greater oxidative damage than does nuclear DNA in human tissues. Uremic patients are subject to a state of enhanced oxidative stress due to excess production of oxidants and a defective antioxidant defense system. This study was conducted to investigate mtDNA mutations and oxidative damage in skeletal muscle of patients with chronic uremia. Results showed that large-scale deletions between nucleotide position (np) 7,900 and 16,300 of mtDNA occurred at a high frequency in muscle of uremic patients. Among them, the 4,977-bp deletion (mtDNA(4977)) was the most frequent and most abundant large-scale mtDNA deletion in uremic skeletal muscle. The proportion of mtDNA(4977) was found to correlate positively with the level of 8-hydroxy 2'-deoxyguanosine (8-OHdG) in the total DNA of skeletal muscle (r = 0.62, p < 0.05). Using long-range PCR and DNA sequencing, we identified and characterized multiple deletions of mtDNA in skeletal muscle of 16 of 19 uremic patients examined. The 8,041-bp deletion, which occurred between np 8035 and 16,075, was flanked by a 5-bp direct repeat of 5'-CCCAT-3'. Some of the deletions were found in more than 1 patient. On the other hand, we found that the mean 8-OHdG/10(5 )dG ratio in the total cellular DNA of muscle of uremic patients was significantly higher than that of the controls (182.7 +/- 63.6 vs. 50.9 +/- 21.5, p = 0.05). In addition, the mean 8-OHdG/10(5 )dG ratio in muscle mtDNA of uremic patients was significantly higher than that in nuclear DNA (344.0 +/- 56.9 vs. 146.3 +/- 95.8, p = 0.001). Moreover, we found that the average content of lipid peroxides in mitochondrial membranes of skeletal muscle of uremic patients was significantly higher than that of age-matched healthy subjects (23.76 +/- 6.06 vs. 7.67 +/- 0.95 nmol/mg protein; p < 0.05). The average content of protein carbonyls in the mitochondrial membranes prepared from uremic skeletal muscles was significantly higher than that in normal controls (24.90 +/- 4.00 vs. 14.48 +/- 1.13 nmol/mg protein; p < 0.05). Taken together, these findings suggest that chronic uremia leads to mtDNA mutations together with enhanced oxidative damage to DNA, lipids, and proteins of mitochondria in skeletal muscle, which may contribute to the impairment of mitochondrial bioenergetic function and to skeletal myopathy commonly seen in uremic patients. Copyright 2002 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372993     DOI: 10.1159/000064728

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  13 in total

1.  Mitochondrial DNA injury and mortality in hemodialysis patients.

Authors:  Madhumathi Rao; Lijun Li; Caren Demello; Daqing Guo; Bertrand L Jaber; Brian J G Pereira; Vaidyanathapuram S Balakrishnan
Journal:  J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 10.121

2.  Chronic oxidative stress as a mechanism for radiation nephropathy.

Authors:  Marek Lenarczyk; Eric P Cohen; Brian L Fish; Amy A Irving; Mukut Sharma; Collin D Driscoll; John E Moulder
Journal:  Radiat Res       Date:  2009-02       Impact factor: 2.841

Review 3.  Aging and uremia: Is there cellular and molecular crossover?

Authors:  William E White; Muhammad M Yaqoob; Steven M Harwood
Journal:  World J Nephrol       Date:  2015-02-06

4.  Differential network enrichment analysis reveals novel lipid pathways in chronic kidney disease.

Authors:  Jing Ma; Alla Karnovsky; Farsad Afshinnia; Janis Wigginton; Daniel J Rader; Loki Natarajan; Kumar Sharma; Anna C Porter; Mahboob Rahman; Jiang He; Lee Hamm; Tariq Shafi; Debbie Gipson; Crystal Gadegbeku; Harold Feldman; George Michailidis; Subramaniam Pennathur
Journal:  Bioinformatics       Date:  2019-09-15       Impact factor: 6.937

5.  Metabolite profiling identifies markers of uremia.

Authors:  Eugene P Rhee; Amanda Souza; Laurie Farrell; Martin R Pollak; Gregory D Lewis; David J R Steele; Ravi Thadhani; Clary B Clish; Anna Greka; Robert E Gerszten
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

6.  Resistance training increases muscle mitochondrial biogenesis in patients with chronic kidney disease.

Authors:  Vaidyanatha S Balakrishnan; Madhumathi Rao; Vandana Menon; Patricia L Gordon; Monika Pilichowska; Francisco Castaneda; Carmen Castaneda-Sceppa
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

7.  Mitochondrial DNA deletions inhibit proteasomal activity and stimulate an autophagic transcript.

Authors:  Mansour Alemi; Alessandro Prigione; Alice Wong; Robert Schoenfeld; Salvatore DiMauro; Michio Hirano; Franco Taroni; Gino Cortopassi
Journal:  Free Radic Biol Med       Date:  2006-09-19       Impact factor: 7.376

8.  Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients.

Authors:  Nicole Schupp; Eva Maria Dette; Ursula Schmid; Udo Bahner; Michaela Winkler; August Heidland; Helga Stopper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-29       Impact factor: 3.000

9.  Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD.

Authors:  Farsad Afshinnia; Thekkelnaycke M Rajendiran; Tanu Soni; Jaeman Byun; Stefanie Wernisch; Kelli M Sas; Jennifer Hawkins; Keith Bellovich; Debbie Gipson; George Michailidis; Subramaniam Pennathur
Journal:  J Am Soc Nephrol       Date:  2017-10-11       Impact factor: 10.121

Review 10.  Genomic damage in endstage renal disease-contribution of uremic toxins.

Authors:  Nicole Schupp; August Heidland; Helga Stopper
Journal:  Toxins (Basel)       Date:  2010-10-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.